ES348804A1 - Derivatives of 3-Amino-1,2-Propanediol and their process of preparation - Google Patents

Derivatives of 3-Amino-1,2-Propanediol and their process of preparation

Info

Publication number
ES348804A1
ES348804A1 ES348804A ES348804A ES348804A1 ES 348804 A1 ES348804 A1 ES 348804A1 ES 348804 A ES348804 A ES 348804A ES 348804 A ES348804 A ES 348804A ES 348804 A1 ES348804 A1 ES 348804A1
Authority
ES
Spain
Prior art keywords
radical
compounds
araliphatic
propanediol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES348804A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Publication of ES348804A1 publication Critical patent/ES348804A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compounds of the general formula (R 1 , 2 = H, saturated or unsaturated C 1-5 aliphatic radical, alicyclic radical, araliphatic or substituted araliphatic radical or phenyl or substituted phenyl radical, or -NR 1 R 2 = heterocyclic radical) and their acid addition and quaternary ammonium salts are prepared by reacting 1-propargyloxy-2,3-epoxypropane with R 1 R 2 NH, optionally followed by salt formation. The compounds of the invention possess cardiovascular, analgesic and sedative activity, and may be administered in the form of pharmaceutical preparations containing them together with a carrier.
ES348804A 1966-12-30 1967-12-29 Derivatives of 3-Amino-1,2-Propanediol and their process of preparation Expired ES348804A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB58260/66A GB1157910A (en) 1966-12-30 1966-12-30 Derivatives of 3-Amino-1,2-Propanediol and their process of preparation

Publications (1)

Publication Number Publication Date
ES348804A1 true ES348804A1 (en) 1969-03-16

Family

ID=10481157

Family Applications (1)

Application Number Title Priority Date Filing Date
ES348804A Expired ES348804A1 (en) 1966-12-30 1967-12-29 Derivatives of 3-Amino-1,2-Propanediol and their process of preparation

Country Status (8)

Country Link
BE (1) BE707719A (en)
CH (1) CH478089A (en)
DE (1) DE1643913B1 (en)
ES (1) ES348804A1 (en)
FR (2) FR1567131A (en)
GB (1) GB1157910A (en)
NL (2) NL6800004A (en)
SE (1) SE326175B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2479813A1 (en) * 1980-04-04 1981-10-09 Fabre Sa Pierre ALCOXY PROPANOLAMINES USEFUL AS MEDICAMENTS AND PROCESS FOR THEIR PREPARATION
DK160818C (en) * 1983-12-30 1991-10-07 Hoffmann La Roche N-RING containing glycerol derivatives, processes for their preparation, their use for the preparation of a platelet activation factor inhibitor, and drugs containing such a compound

Also Published As

Publication number Publication date
NL6800004A (en) 1968-07-01
DE1643913B1 (en) 1972-06-29
BE707719A (en) 1968-06-10
FR7113M (en) 1969-07-15
NL133296C (en)
CH478089A (en) 1969-09-15
SE326175B (en) 1970-07-20
GB1157910A (en) 1969-07-09
FR1567131A (en) 1969-05-16

Similar Documents

Publication Publication Date Title
GB1140860A (en) Isopropanolamine derivatives, their preparation, and pharmaceutical compositions containing them
GB1083193A (en) Guanidine derivatives and process for their manufacture
GB1198317A (en) Benzophenone Derivatives
GB1137764A (en) Improvements in or relating to pharmacologically-active secondary amines
ES335340A1 (en) 1-(alkynylphenoxy)-2-hydroxy-3-aminopropanes and the salts thereof
ES348804A1 (en) Derivatives of 3-Amino-1,2-Propanediol and their process of preparation
GB1504862A (en) Terpeno-phenoxyalkylamines
GB1138315A (en) 2-amino-benzylamines
GB1371757A (en) Substituted aminoquinolizinium bromides their preparation and compositions thereof
GB1451389A (en) Indolobenzazepines
GB1073521A (en) Indole derivatives
ES348211A1 (en) 11h-dibenzo(1,2,5)triaz 2 nes and their salts
GB1363986A (en) Diphenylmethoxyethylamines
ES343446A1 (en) Drug with hypertensive action on the base of 1-(3 4 - dimethoxy - 4-hydroxyphenyl)-2-monomethylaminoethanol
GB1138968A (en) Improvements in or relating to indole derivatives
GB1132397A (en) Improvements in or relating to fluorene derivatives and the manufacture thereof
GB1171827A (en) Improvements in or relating to Substituted Propanols and the Manufacture thereof
ES361103A1 (en) Novel amines with pharmaceutical applications
GB1160448A (en) Alkanolamine Derivatives
ES393894A1 (en) Piperidinemethyl ethers
GB1067694A (en) A process for the preparation of 2-alkyl-4-alkylamino-6-alkoxy-s-triazines
GB1373271A (en) Indoles
GB1294159A (en) Derivatives of 1-amino-3-phenoxy-propan-2-ol, and processes for preparing them
ES360460A1 (en) Improvements in or relating to nitrogen-containing heterocyclic derivatives
GB1338480A (en) Amines and process for their preparation